CARDiac Toxicity Following ImmunOtherapy Treatment for Melanoma

Clinical trial NCT06605833 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06605833
Sponsor: Royal Marsden NHS Foundation Trust
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Melanoma Stage III or IV

Start date: 2025-09-26
Primary completion: 2026-09-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.